诚意药业
(603811)
| 流通市值：31.48亿 | | | 总市值：31.48亿 |
| 流通股本：4.58亿 | | | 总股本：4.58亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 166,370,406.01 | 268,783,691.37 | 220,703,850.99 | 205,125,531.51 |
| 应收票据及应收账款 | 34,974,654.81 | 42,027,339.88 | 22,580,501.94 | 38,689,631.8 |
| 应收账款 | 34,974,654.81 | 42,027,339.88 | 22,580,501.94 | 38,689,631.8 |
| 应收款项融资 | 16,243,145.41 | 17,889,911.43 | 16,379,646.23 | 8,267,515.57 |
| 预付款项 | 13,448,390.71 | 13,747,736.3 | 15,539,056.8 | 7,293,958.41 |
| 其他应收款合计 | 14,175,225.47 | 1,763,664.7 | 1,560,113.19 | 2,097,975.28 |
| 应收股利 | 12,600,560 | - | - | - |
| 存货 | 110,058,546.5 | 116,716,383.27 | 116,341,994.19 | 125,324,247.36 |
| 其他流动资产 | 92,153,862.77 | 3,383,447.24 | 2,161,094.8 | 570,576.59 |
| 流动资产合计 | 447,424,231.68 | 464,312,174.19 | 395,491,049.41 | 396,179,491.32 |
| 非流动资产: | | | | |
| 长期股权投资 | 335,179,271.78 | 340,500,984.81 | 336,721,047.61 | 331,720,790.68 |
| 投资性房地产 | 810,580.15 | 840,605.62 | 870,631.09 | 900,656.56 |
| 固定资产 | 826,824,413.32 | 839,550,324.3 | 860,523,471.5 | 883,529,252.79 |
| 在建工程 | 53,372,268.72 | 52,599,145.51 | 30,705,137.4 | 11,162,572.38 |
| 无形资产 | 52,129,906.88 | 52,616,227.49 | 53,020,898.1 | 53,512,130.05 |
| 长期待摊费用 | 251,874.77 | 150,294.76 | 195,565.9 | 246,234.94 |
| 递延所得税资产 | 10,657,390.12 | 10,132,001.07 | 7,995,898.39 | 5,727,088.96 |
| 其他非流动资产 | 24,621,393.71 | 19,729,570.62 | 16,825,184.74 | 8,616,780 |
| 非流动资产合计 | 1,303,847,099.45 | 1,316,119,154.18 | 1,306,857,834.73 | 1,295,415,506.36 |
| 资产总计 | 1,751,271,331.13 | 1,780,431,328.37 | 1,702,348,884.14 | 1,691,594,997.68 |
| 流动负债: | | | | |
| 短期借款 | 24,910,481.67 | 15,003,590.28 | 15,011,840.28 | 55,095,534.72 |
| 应付票据及应付账款 | 48,856,099.72 | 43,624,441.87 | 53,690,502.13 | 49,890,303.32 |
| 其中：应付票据 | 11,231,090 | 5,140,000 | 140,000 | - |
| 应付账款 | 37,625,009.72 | 38,484,441.87 | 53,550,502.13 | 49,890,303.32 |
| 合同负债 | 21,520,525.34 | 19,179,968.54 | 7,591,826.11 | 8,530,345.02 |
| 应付职工薪酬 | 10,668,729.17 | 22,166,971.52 | 28,382,063.07 | 13,821,079.55 |
| 应交税费 | 25,112,283.7 | 30,467,951.64 | 28,786,643.25 | 17,900,057.26 |
| 其他应付款合计 | 117,351,120.14 | 116,881,876.06 | 115,226,920.15 | 125,608,730.26 |
| 一年内到期的非流动负债 | 16,945,710.36 | 17,047,835.42 | 17,043,411.99 | 3,062,533.84 |
| 其他流动负债 | 1,336,965.01 | 1,763,441.68 | 600,960.78 | 1,085,002.45 |
| 流动负债合计 | 266,701,915.11 | 266,136,077.01 | 266,334,167.76 | 274,993,586.42 |
| 非流动负债: | | | | |
| 长期借款 | 24,996,099.05 | 23,004,865.69 | 5,696,975.96 | 58,608,000 |
| 递延收益 | 20,826,665.58 | 21,124,973.52 | 20,420,212.5 | 16,598,631.32 |
| 递延所得税负债 | 11,285,247.33 | 11,693,702.11 | 12,102,156.88 | 12,510,611.65 |
| 非流动负债合计 | 57,108,011.96 | 55,823,541.32 | 38,219,345.34 | 87,717,242.97 |
| 负债合计 | 323,809,927.07 | 321,959,618.33 | 304,553,513.1 | 362,710,829.39 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 458,226,048 | 327,304,320 | 327,304,320 | 327,304,320 |
| 资本公积 | 39,890,359.74 | 154,759,519.56 | 138,706,951.38 | 122,654,383.22 |
| 减:库存股 | 48,286,356 | 48,286,356 | 48,286,356 | 48,286,356 |
| 盈余公积 | 152,704,393.13 | 152,704,393.13 | 152,704,393.13 | 138,586,838.77 |
| 未分配利润 | 816,713,153.03 | 864,325,502.24 | 820,035,756.79 | 781,760,120.8 |
| 归属于母公司股东权益合计 | 1,419,247,597.9 | 1,450,807,378.93 | 1,390,465,065.3 | 1,322,019,306.79 |
| 少数股东权益 | 8,213,806.16 | 7,664,331.11 | 7,330,305.74 | 6,864,861.5 |
| 股东权益合计 | 1,427,461,404.06 | 1,458,471,710.04 | 1,397,795,371.04 | 1,328,884,168.29 |
| 负债和股东权益合计 | 1,751,271,331.13 | 1,780,431,328.37 | 1,702,348,884.14 | 1,691,594,997.68 |
| 公告日期 | 2026-08-27 | 2026-04-24 | 2026-04-24 | 2025-10-28 |
| 审计意见(境内) | | | 标准无保留意见 | |